Medicine


Showing 851-860 of 1,153 Results

  • Farhana Rob, DO

    Farhana Rob, DO

    Clinical Assistant Professor, Medicine - Primary Care and Population Health

    BioDr. Farhana Rob is a board-certified, fellowship-trained family medicine doctor with Stanford Health Care. She is also a clinical assistant professor in the Department of Medicine, Primary Care and Population Health at Stanford University School of Medicine.

    Dr. Rob provides personalized and compassionate primary care for people ranging from newborns to older adults. She specializes in women’s health and maternity care, managing conditions such as heavy menstrual bleeding, pregnancy-induced hypertension, and gestational diabetes. She also has expertise in birth control, discussing and providing options particularly for adolescents and postpartum mothers. Dr. Rob also specializes in minor injuries and musculoskeletal problems, providing therapies such as laceration repair, tendon and joint injections, and trigger point injections.

    Dr. Rob emphasizes preventive care and early diagnosis through routine and diagnostic screenings. She strives to empower them to become active participants in their health care. She is open to discussing alternative and natural treatments to support holistic healing. Dr. Rob also enjoys teaching and has mentored medical students and residents throughout her career.

    Dr. Rob has published research on heart failure in peer-reviewed journals including the Journal of Cardiovascular Electrophysiology. She shared her findings on using ultrasound to estimate birthweight at the American Academy of Family Physicians Family-Centered Pregnancy Care Conference. She has also written about heavy menstrual bleeding for The 5-Minute Clinical Consult, a physician guidebook that focuses on evidence-based medicine.

    Dr. Rob is a member of the American Academy of Family Physicians, the American Board of Family Medicine, and the American Medical Association.

  • Thomas Robinson

    Thomas Robinson

    The Irving Schulman, M.D. Professor of Child Health, Professor of Medicine (Stanford Prevention Research Center) and, by courtesy, of Epidemiology and Population Health

    Current Research and Scholarly InterestsDr. Robinson originated the solution-oriented research paradigm and directs the Stanford Solutions Science Lab. He is known for his pioneering obesity prevention and treatment research, including the concept of stealth interventions. His research applies social cognitive models of behavior change to behavioral, social, environmental and policy interventions for children and families in real world settings, making the results relevant for informing clinical and public health practice and policy.

  • William H. Robinson, MD PhD

    William H. Robinson, MD PhD

    James W. Raitt, M.D. Professor

    Current Research and Scholarly InterestsOur lab investigates the molecular mechanisms of and develops therapies to treat autoimmune and rheumatic diseases, with a focus on rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, and osteoarthritis.

    The overriding objectives of our laboratory are:
    1. To elucidate the mechanisms underlying autoimmune and rheumatic diseases.
    2. To investigate the role of innate immune inflammation in osteoarthritis.
    3. To develop novel diagnostics and therapeutics

  • Stanley G. Rockson, MD

    Stanley G. Rockson, MD

    Allan and Tina Neill Professor of Lymphatic Research and Medicine

    Current Research and Scholarly InterestsMy clinical research includes studies on risk factor modification in atherosclerosis and coronary artery disease; clinical trials involving medical therapies for peripheral arterial insufficiency; coronary angiogenesis; therapy of lymphedema; atherand photodynamic therapy in atherosclerosis.

  • Fatima Rodriguez

    Fatima Rodriguez

    Associate Professor of Medicine (Cardiovascular Medicine)

    BioFatima Rodriguez, MD, MPH serves as the Vice Chair of Clinical Research (Department of Medicine), Section Chief of Preventive Cardiology, and Associate Director of the Center for Digital Health at Stanford University. She received her medical degree from Harvard Medical School and a Master of Public Health from the Harvard T.H. Chan School of Public Health. Dr. Rodriguez completed her internal medicine residency at Brigham and Women’s Hospital and fellowship in cardiovascular medicine at Stanford.

    Dr. Rodriguez specializes in the prevention and management of cardiovascular disease, with clinical expertise in coronary artery disease and inherited lipid disorders. Her research focuses on cardiovascular disease prevention and health promotion, leveraging digital tools to improve guideline-based care, and using AI-enabled approaches for early detection of atherosclerosis.

  • Stephan Rogalla, M.D. Ph.D.

    Stephan Rogalla, M.D. Ph.D.

    Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
    Affiliate, Medicine - Med/Gastroenterology and Hepatology

    Current Research and Scholarly InterestsThe research interest of myself and my lab are in the field of early cancer detection using targeted molecular spies to highlight (pre)cancerous lesions. We as well aim to improve precision medicine in autoimmune disorders like inflammatory bowel disease and oncology.

  • Albert "A.J." Rogers, MD, MBA, FAHA

    Albert "A.J." Rogers, MD, MBA, FAHA

    Instructor, Medicine - Cardiovascular Medicine

    BioDr. Rogers is a board-certified, fellowship-trained cardiologist with the Cardiac Arrhythmia Service at Stanford Health Care. He is also an instructor of medicine in the Division of Cardiovascular Medicine, Department of Medicine at Stanford University School of Medicine.

    As a clinical cardiac electrophysiologist, Dr. Rogers’ training includes evaluating issues involving electrical activity in the heart and how these can lead to an abnormal heart rhythm (arrhythmia). His expertise includes mapping regions in the heart associated with arrhythmias and then applying a minimally invasive therapy (ablation) that targets the responsible areas causing the problem. He also performs procedures to implant cardiac devices, such as pacemakers and defibrillators, designed to synchronize heart contractions and reset irregular heartbeats.

    Dr. Rogers specializes in the diagnosis and treatment of atrial fibrillation, ventricular tachycardia, and other arrhythmias. In collaboration with Stanford Medicine cardiovascular surgeons, he performs hybrid surgical-catheter ablation procedures as a more permanent treatment for persistent forms of atrial fibrillation and for inappropriate sinus tachycardia. During this procedure, ablation therapy is applied to areas both inside and outside of the heart responsible for the arrhythmia.

    As a physician-researcher, Dr. Rogers’ translational research applies biomedical engineering and machine learning approaches to explore the mechanisms underlying cardiac arrhythmia. These efforts include research funded by the National Institutes of Health and the American Heart Association to investigate novel methods for diagnosing and treating heart rhythm disorders. Dr. Rogers has over 10 years of experience with medical technology innovation and development.

    Dr. Rogers serves as associate editor of the Journal of Invasive Cardiovascular Electrophysiology. He is also a peer reviewer for multiple prestigious journals, including Heart Rhythm, The Lancet: Digital Health, the Journal of the American College of Cardiology: Clinical Electrophysiology, and Frontiers in Physiology. He has been an invited guest speaker at national and international meetings, including those for the American Heart Association and the European Cardiac Arrythmia Society.

  • Angela Rogers

    Angela Rogers

    Professor of Medicine (Pulmonary and Critical Care)

    Current Research and Scholarly InterestsWe use genetics and genomics methodologies to identify novel ARDS pathobiology; we hope that this will enable identification of novel biomarkers, phenotypes, and treatments for the disease. We are building a plasma biobank of critically ill patients at Stanford, with a particular focus on metabolic changes in critical illness.